# Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer

> **NCT03825861** · PHASE2 · RECRUITING · sponsor: **Instituto do Cancer do Estado de São Paulo** · enrollment: 27 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** FOLFIRINOX

## Key facts

- **NCT ID:** NCT03825861
- **Lead sponsor:** Instituto do Cancer do Estado de São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-02-23
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2020-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03825861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03825861, "Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT03825861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*